These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15726299)

  • 1. [Rashes in HIV-infected patients undergoing therapy with nevirapine or efavirenz].
    Hartmann M; Brust J; Schuster D; Mosthaf F; Procaccianti M; Rump JA; Klinker H; Petzoldt D
    Hautarzt; 2005 Sep; 56(9):847-53. PubMed ID: 15726299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and risk factors of rash associated with efavirenz in HIV-infected patients with preceding nevirapine-associated rash.
    Manosuthi W; Thongyen S; Chumpathat N; Muangchana K; Sungkanuparph S
    HIV Med; 2006 Sep; 7(6):378-82. PubMed ID: 16903982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of the non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz in the treatment of patients with a chronic HIV-I infection].
    van Leth F; Lange JM
    Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1719-22. PubMed ID: 16924943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent and importance of cross-resistance to efavirenz after nevirapine failure.
    Casado JL; Moreno A; Hertogs K; Dronda F; Moreno S
    AIDS Res Hum Retroviruses; 2002 Jul; 18(11):771-5. PubMed ID: 12167268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nevirapine + efavirenz based salvage therapy in heavily pretreated HIV infected patients.
    Olivieri J
    Sex Transm Infect; 2002 Feb; 78(1):72-3. PubMed ID: 11872871
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen.
    Delaugerre C; Rohban R; Simon A; Mouroux M; Tricot C; Agher R; Huraux JM; Katlama C; Calvez V
    J Med Virol; 2001 Nov; 65(3):445-8. PubMed ID: 11596076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efavirenz replacement by immediate full-dose nevirapine is safe in HIV-1-infected patients in Cambodia.
    Laureillard D; Prak N; Fernandez M; Ngeth C; Moeung S; Riel V; Chhneang V; Song S; Quillet C; Piketty C
    HIV Med; 2008 Aug; 9(7):514-8. PubMed ID: 18554312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tolerability of efavirenz after nevirapine-related adverse events.
    Clarke S; Harrington P; Barry M; Mulcahy F
    Clin Infect Dis; 2000 Sep; 31(3):806-7. PubMed ID: 11017835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nevirapine versus efavirenz based antiretroviral treatment in naive Indian patients: comparison of effectiveness in clinical cohort.
    Patel AK; Pujari S; Patel K; Patel J; Shah N; Patel B; Gupte N
    J Assoc Physicians India; 2006 Dec; 54():915-8. PubMed ID: 17334006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk factors of skin rashes and hepatotoxicity in HIV-infected patients receiving nevirapine-containing combination antiretroviral therapy in Taiwan.
    Tseng YT; Yang CJ; Chang SY; Lin SW; Tsai MS; Liu WC; Wu PY; Su YC; Luo YZ; Yang SP; Hung CC; Chang SC
    Int J Infect Dis; 2014 Dec; 29():12-7. PubMed ID: 25312984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative biological and clinical outcomes after a switch from a virologically unsuccessful first protease inhibitor-containing antiretroviral combination to a 3-drug regimen containing efavirenz, nevirapine, or abacavir.
    Abgrall S; Yeni PG; Bouchaud O; Costagliola D;
    Clin Infect Dis; 2007 Jan; 44(1):120-7. PubMed ID: 17143827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Decrease of HIV-1 virus load by nevirapin/efavirenz].
    Dtsch Med Wochenschr; 2003 May; 128(19):1075. PubMed ID: 12774797
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of nevirapine- and efavirenz-containing antiretroviral regimens in antiretroviral-naïve patients: a cohort study.
    Keiser P; Nassar N; White C; Koen G; Moreno S
    HIV Clin Trials; 2002; 3(4):296-303. PubMed ID: 12187503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in the treatment of HIV.
    Sheran M
    HIV Clin Trials; 2005; 6(3):158-68. PubMed ID: 16192249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults.
    Nachega JB; Hislop M; Dowdy DW; Gallant JE; Chaisson RE; Regensberg L; Maartens G
    AIDS; 2008 Oct; 22(16):2117-25. PubMed ID: 18832875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of efficacy of efavirenz and nevirapine: lessons learned for cohort analysis in light of the 2NN Study.
    Keiser P; Nassar N; Yazdani B; Armas L; Moreno S
    HIV Clin Trials; 2003; 4(5):358-60. PubMed ID: 14583852
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV/AIDS news: comparable anti-HIV antiviral efficacy of Viramune and Efavirenz--the Lancet publishes first large-scale comparison study.
    Meyer-Kleinmann J
    Infection; 2004 Jun; 32(3):7. PubMed ID: 15230276
    [No Abstract]   [Full Text] [Related]  

  • 18. Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial.
    Bonnet M; Bhatt N; Baudin E; Silva C; Michon C; Taburet AM; Ciaffi L; Sobry A; Bastos R; Nunes E; Rouzioux C; Jani I; Calmy A;
    Lancet Infect Dis; 2013 Apr; 13(4):303-12. PubMed ID: 23433590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and determinants of nevirapine and efavirenz-related skin rashes in West Africans: nevirapine's epitaph?
    Sarfo FS; Sarfo MA; Norman B; Phillips R; Chadwick D
    PLoS One; 2014; 9(4):e94854. PubMed ID: 24728406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can early failure with nevirapine be rescued with efavirenz?
    Briones C; Soriano V; Dona C; Barreiro P; González-Lahoz J
    J Acquir Immune Defic Syndr; 2000 May; 24(1):76-8. PubMed ID: 10877499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.